CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $369,078 | -15.3% | 66,862 | +31.0% | 0.00% | – |
| Q2 2023 | $435,975 | -36.8% | 51,051 | -32.0% | 0.00% | – |
| Q1 2023 | $690,113 | +19.7% | 75,094 | +33.0% | 0.00% | – |
| Q4 2022 | $576,426 | -24.3% | 56,457 | +9.3% | 0.00% | – |
| Q3 2022 | $761,000 | +23.5% | 51,667 | -10.0% | 0.00% | – |
| Q2 2022 | $616,000 | +4.8% | 57,392 | +5.1% | 0.00% | – |
| Q1 2022 | $588,000 | +245.9% | 54,584 | +423.9% | 0.00% | – |
| Q4 2021 | $170,000 | -19.8% | 10,419 | +5.5% | 0.00% | – |
| Q3 2021 | $212,000 | – | 9,876 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |